# Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma

> **NCT07240610** · — · RECRUITING · sponsor: **Zhe Chen** · enrollment: 145 (estimated)

## Conditions studied

- Renal Cell Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07240610
- **Lead sponsor:** Zhe Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-10
- **Primary completion:** 2028-03-31
- **Final completion:** 2029-09-30
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07240610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07240610, "Abscopal Effect of Ultra-Hypofractionated Radiation Plus Immunotherapy in Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07240610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*